Resources Contact Us Home
Systems and methods for authorizing a client in an SSL VPN session failover environment

Image Number 19 for United States Patent #8132247.

The SSL VPN session failover solution of the appliance and/or client agent described herein provides an environment for handling IP address assignment and end point re-authorization upon failover. The appliances may be deployed to provide a session failover environment in which a second appliance is a backup to a first appliance when a failover condition is detected, such as failure in operation of the first appliance. The backup appliance takes over responsibility for SSL VPN sessions provided by the first appliance. In the failover environment, the first appliance propagates SSL VPN session information including user IP address assignment and end point authorization information to the backup appliance. The backup appliance maintains this information. Upon detection of failover of the first appliance, the backup appliance activates the transferred SSL VPN session and maintains the user assigned IP addresses. The backup appliance may also re-authorize the client for the transferred SSL VPN session.

  Recently Added Patents
Datacenter utilizing modular infrastructure systems and redundancy protection from failure
Systems, methods, and language for SCA CORBA descriptor files
Call management and notifications in media player applications
Current mode sense amplifier with passive load
Headlight for motor vehicle
Dryer bar
Low smoke, fire and water resistant cable coating
  Randomly Featured Patents
Method and apparatus for the detection of stagnant regions in a fluidized bed or in pneumatic conveying lines
Photonic-integrated-circuit fabrication process
Heat-sensitive stencil and method of fabricating same
Luggage case
System for carrying out and managing animal feedlot operations using coordinate acquisition techniques
Carrying cart equipped with service rack and stepladder
Automatic noninvasive blood pressure monitor
Covered jug
Cryogenically controlled direct fluorination apparatus
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use